Alisol A Inhibited the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells by Inhibiting the Hippo Signaling Pathway
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Alisol A is a bioactive triterpenoid isolated from the Rhizoma Alismatis. Previous studies have shown that alisol A has anticancer potential. In this study, we explored the effect of alisol A on the growth of nasopharyngeal carcinoma (NPC) cells. Materials and Methods: MTT assay, colony formation assay, flow cytometry, transwell assay, wound healing assay, and western blotting were used to assess cell viability, proliferation, cell cycle, migration, invasion, and protein expression, respectively, in vitro. AutoDock Vina and Discovery Studio software were used for molecular docking. Results: Alisol A inhibited the viability, proliferation, migration, and invasion of NPC cells. The molecular docking simulation assay confirmed that alisol A bound to YAP protein. In addition, alisol A promoted the phosphorylation of YAP and suppressed the expression of YAP in NPC cells. Conclusion: Alisol A inhibited the proliferation, migration, and invasion of NPC cells by inhibiting the Hippo signaling pathway. Alisol A may be a candidate drug for NPC.
Abstract
Purpose: Alisol A is a bioactive triterpenoid isolated from the Rhizoma Alismatis. Previous studies have shown that alisol A has anticancer potential. In this study, we explored the effect of alisol A on the growth of nasopharyngeal carcinoma (NPC) cells. Materials and Methods: MTT assay, colony formation assay, flow cytometry, transwell assay, wound healing assay, and western blotting were used to assess cell viability, proliferation, cell cycle, migration, invasion, and protein expression, respectively, in vitro. AutoDock Vina and Discovery Studio software were used for molecular docking. Results: Alisol A inhibited the viability, proliferation, migration, and invasion of NPC cells. The molecular docking simulation assay confirmed that alisol A bound to YAP protein. In addition, alisol A promoted the phosphorylation of YAP and suppressed the expression of YAP in NPC cells. Conclusion: Alisol A inhibited the proliferation, migration, and invasion of NPC cells by inhibiting the Hippo signaling pathway. Alisol A may be a candidate drug for NPC.
참고문헌 (39)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- Fan C, "The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma", J Cancer, 9, pp.2852~2864 (2018)
- Lin DC, "The genomic landscape of nasopharyngeal carcinoma", Nat Genet, 46, pp.866~871 (2014)
- Chang ET, "Active and passive smoking and risk of nasopharyngeal carcinoma : a population-based case-control study in Southern China", Am J Epidemiol, 185, pp.1272~1280 (2017)
- Nakanishi Y, "Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma", Cancer Metastasis Rev, 36, pp.435~447 (2017)
- Wang K, "Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma", BMC Cancer, 19, pp.482~ (2019)
- Yuan R, "Natural products to prevent drug resistance in cancer chemotherapy : a review", Ann N Y Acad Sci, 1401, pp.19~27 (2017)
- Sharifi-Rad J, "Natural products and synthetic analogs as a source of antitumor drugs", Biomolecules, 9, pp.679~ (2019)
- Tian T, "Traditional uses, phytochemistry, pharmacology, toxicology and quality control of Alisma orientale (Sam.)Juzep: a review", J Ethnopharmacol, 158(Pt A), pp.373~387 (2014)
- Zhou X, "Alisol A 24-acetate isolated from the Alismatis Rhizoma improves hepatic lipid deposition in hyperlipidemic mice by ABCA1", ABCG1 pathway, 2019, pp.19, 5496~5502
- Li Q, "Study on the hypoglycemic activities and metabolism of alcohol extract of Alismatis Rhizoma", Fitoterapia, 83, pp.1046~1053 (2012)
- Liu SS, "Chemical constituents from Alismatis Rhizoma and their anti-inflammatory activities in vitro and in vivo", Bioorg Chem, 92, pp.103226~ (2019)
- Meng Q, "Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation", Acta Pharmacol Sin, 38, pp.69~79 (2017)
- Jiang ZY, "A new triterpene and anti-hepatitis B virus active compounds from Alisma orientalis", Planta Med, 72, pp.951~954 (2006)
- Hong-Guang Jin, "A New Triterpenoid from Alisma orientale and Their Antibacterial Effect", Archives of Pharmacal Research, 35(11), pp.1919~1926 (2012), 대한약학회
- Zhang LL, "Effects of alisol B 23-acetate on ovarian cancer cells : G1 phase cell cycle arrest, apoptosis, migration and invasion inhibition", Phytomedicine, 23, pp.800~809 (2016)
- Xu W, "Anti-proliferative activities of terpenoids isolated from Alisma orientalis and their structure-activity relationships", Anticancer Agents Med Chem, 15, pp.228~235 (2015)
- Lou C, "Alisol A suppresses proliferation, migration, and invasion in human breast cancer MDA-MB-231 cells", Molecules, 24, pp.3651~ (2019)
- Moon S, "Regulation of the Hippo pathway in cancer biology", Cell Mol Life Sci, 75, pp.2303~2319 (2018)
- Ahmed AA, "YAP and the Hippo pathway in pediatric cancer", Mol Cell Oncol, 4, pp.e1295127~ (2017)
- Geromichalos GD, "Importance of molecular computer modeling in anticancer drug development", J BUON, 12, pp.S101~S118 (2007)
- Xiang Y, "Traditional Chinese medicine as a cancer treatment : modern perspectives of ancient but advanced science", Cancer Med, 8, pp.1958~1975 (2019)
- Zhang A, "Antiproliferative activity of Alisol B in MDA-MB-231 cells is mediated by apoptosis, dysregulation of mitochondrial functions, cell cycle arrest and generation of reactive oxygen species", Biomed Pharmacother, 87, pp.110~117 (2017)
- Liu Y, "Alisol B 23 acetate inhibits the viability and induces apoptosis of non small cell lung cancer cells via PI3K", AKT, Mol Med Rep, pp.2019, 20[DOI]
- Xia J, "Alisol B 23-acetate-induced HepG2 hepatoma cell death through mTOR signaling-initiated G1 cell cycle arrest and apoptosis : a quantitative proteomic study", Chin J Cancer Res, 31, pp.375~388 (2019)
- Shapiro GI, "Anticancer drug targets : cell cycle and checkpoint control", J Clin Invest, 104, pp.1645~1653 (1999)
- Simmons Kovacs LA, "Transcription networks and cyclin", CDKs : the yin and yang of cell cycle oscillators, 2008, pp.7, 2626~2629
- Ma Z, "Inhibitory effect of simvastatin in nasopharyngeal carcinoma cells", Exp Ther Med, 17, pp.4477~4484 (2019)
- Pan B, "Inhibition of prostate cancer growth by solanine requires the suppression of cell cycle proteins and the activation of ROS", P38 signaling pathway, 2016, pp.5, 3214~3222
- Polette M, "Tumour invasion and matrix metalloproteinases", Crit Rev Oncol Hematol, 49, pp.179~186 (2004)
- Chen K, "Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway", PLoS One, 8, pp.e72927~ (2013)
- Du P, "Downregulation of microRNA-1246 inhibits tumor growth and promotes apoptosis of cervical cancer cells by targeting thrombospondin-2", Oncol Lett, 18, pp.2491~2499 (2019)
- Xue XH, "Alisol A 24-acetate, a triterpenoid derived from Alisma orientale, inhibits OxLDL-induced phenotypic transformation and migration of rat vascular smooth muscle cells through suppressing ERK1", 2 signaling, 2016, pp.53, 291~300
- Plouffe SW, "Disease implications of the Hippo", YAP pathway, 2015, pp.21, 212~222
- Gao L, "LncRNA THOR attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells via enhancing cells stemness", Biochimie, 152, pp.63~72 (2018)
- Harvey K, "The Salvador-Warts-Hippo pathway-an emerging tumour-suppressor network", Nat Rev Cancer, 7, pp.182~191 (2007)
- Chen S, "Wogonoside inhibits tumor growth and metastasis in endometrial cancer via ER stress-Hippo signaling axis", Acta Biochim Biophys Sin (Shanghai), 51, pp.1096~1105 (2019)
- Jia M, "Corosolic acid inhibits cancer progress through inactivating YAP in hepatocellular carcinoma", Oncol Res, 28, pp.371~383 (2020)
- Li Y, "Artemisinin suppresses hepatocellular carcinoma cell growth, migration and invasion by targeting cellular bioenergetics and Hippo-YAP signaling", Arch Toxicol, 93, pp.3367~3383 (2019)
